STERIS plc (STE)

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Ticker
STE
Exchange
NYSE
Sector
Healthcare
Industry
Medical Devices
Market cap
$24.99B
52-week range
$195.14 - $269.44

Valuation

Share price
$259.61 (close of Nov 18, 2026)
P/E (TTM)
30.40x
Price to book
3.44x
Price to free cash flow
26.67x
Enterprise value
$26.51B
Book value per share
$74.89

Price performance

PeriodChange
1 day+0.85%
5 days+1.30%
1 month+16.59%
3 months+11.71%
6 months+21.96%
Year to date+2.40%
1 year+1.02%
3 years+29.65%
5 years+10.94%
10 years+292.04%
All time+12,487.16%

Short interest

As of
Oct 30, 2026
Short % of float
2.26%
Shares short
2.18M
Days to cover
2.94
Change since prior report
-9.04%
Source
FINRA consolidated short interest

Members of Congress who disclosed STE trades

April McClain Delaney · Gilbert Ray Cisneros · Jared Moskowitz · Kevin Hern · Robert Bresnahan

Super investors holding STE

Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates) · First Eagle Investment (First Eagle Investment Management, LLC)

Profitability and growth

Return on equity
10.87%
Return on invested capital
9.04%
Return on assets
7.29%
Return on capital employed
11.49%
Gross margin
44.25%
Net margin
13.18%
EBITDA margin
26.76%
Revenue growth
8.73%
Net income growth
27.29%
Free cash flow growth
24.99%

Cash flow and balance sheet

Free cash flow yield (TTM)
3.75%
Current ratio
2.05x
Net debt to EBITDA
0.91x

Latest reported year

Period end
Mar 31, 2026
Fiscal year
2026
Revenue
$5.94B
Cost of revenue
$3.31B
Gross profit
$2.63B
EBITDA
$1.59B
Net income
$782.30M
Earnings per share
$7.97
Research and development
$112.90M
Interest expense
$60.70M
Shares outstanding
98.20M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2026-03-31$5.94B$2.63B$782.30M$7.97
2025-03-31$5.46B$2.40B$614.60M$6.24
2024-03-31$5.14B$2.22B$378.20M$3.83
2023-03-31$4.54B$1.98B$107.03M$1.07
2022-03-31$4.22B$1.88B$243.89M$2.50
2021-03-31$3.11B$1.34B$397.40M$4.66
2020-03-31$3.03B$1.32B$407.66M$4.81
2019-03-31$2.78B$1.17B$303.72M$3.59
2018-03-31$2.62B$1.09B$290.92M$3.42
2017-03-31$2.61B$1.03B$109.97M$1.29

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2026-03-3144.25%13.18%10.87%9.04%
2025-03-3144.01%11.26%9.29%7.73%
2024-03-3143.17%7.36%5.99%7.08%
2023-03-3143.66%2.36%1.76%7.15%
2022-03-3144.59%5.77%3.73%4.03%
2021-03-3143.22%12.79%10.21%7.51%
2020-03-3143.55%13.45%11.93%9.77%
2019-03-3142.23%10.92%9.50%7.92%
2018-03-3141.71%11.10%9.04%7.42%
2017-03-3139.28%4.21%3.91%3.55%

Cash and debt by year

Period endCashDebt
2026-03-31$439.60M$1.81B
2025-03-31$171.70M$1.92B
2024-03-31$207.00M$3.12B
2023-03-31$208.40M$3.02B
2022-03-31$348.32M$2.95B
2021-03-31$220.53M$1.65B
2020-03-31$319.58M$1.15B
2019-03-31$220.63M$1.18B
2018-03-31$201.53M$1.32B
2017-03-31$282.92M$1.48B

Free cash flow by year

Period endFree cash flowStock-based compensation
2026-03-31$972.40M$61.70M
2025-03-31$778.00M$57.40M
2024-03-31$613.00M$56.50M
2023-03-31$394.98M$38.95M
2022-03-31$397.25M$57.66M
2021-03-31$450.38M$25.97M
2020-03-31$376.04M$23.81M
2019-03-31$349.79M$23.96M
2018-03-31$292.18M$22.19M
2017-03-31$251.19M$18.79M

Dividend history

Most recent payment
Sep 4, 2026
Payment dateDividend per share
2026-09-04$0.69
2026-06-08$0.63
2026-02-17$0.63
2025-09-04$0.63
2025-06-10$0.57
2025-02-20$0.57
2024-11-19$0.57
2024-09-05$0.57

Investor relations

Past earnings dates

ReportedFiscal periodEPS estimate
2026-11-04Sep 2026$2.67
2026-08-05Jun 2026$2.54
2026-05-11Mar 2026$2.86
2026-02-04Dec 2025$2.53
2025-11-05Sep 2025$2.38
2025-08-06Jun 2025$2.32
2025-05-14Mar 2025$2.59
2025-02-05Dec 2024$2.32

Filings and sources

Company website
steris.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Zimmer Biomet Holdings, Inc. (ZBH) · Dexcom Inc (DXCM) · Globus Medical Inc (GMED) · GE HealthCare Technologies Inc. (GEHC) · Insulet Corp (PODD) · Edwards Lifesciences Corp (EW) · Boston Scientific Corp (BSX) · Stryker Corp (SYK)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades